News
Significant progress is being made toward diagnosis, evaluation and management of sensori-motor dysfunction, gut microbiota, gut-brain axis, nutrition, eosinophilic esophagitis. Read the most recent news here.
NGM 2021 goes virtual
The European Society of Neurogastroenterology and Motility (ESNM) announces NeuroGASTRO 2021, to be held online due to the corona pandemic. The programme stands under the motto of “Advancing understanding and management in Neurogastroenterology and Motility”. Abstract submission extended until June 30th, 2021.
New Webinars - Save The Date!
Four dates full of Neurogastroenterology and Motility! Join our exciting webinars including the role of genetic factors, diet, microbiota, inflammation, diagnosis and biomarkers, as well as current and future therapeutic approaches.
The course will be held by a distinguished Faculty with expertise in the fields of neurogastroenterology, functional gastrointestinal disorders and microbiota.
Survey: Differences in IBS Care & Training in Europe (DICE Study)
Differences in IBS Care and Training across Europe (DICE Study), supported by ESNM, aims to explore the variations in IBS training and management across Europe. Our current survey will help improve IBS management and make progress of education in this sector of gastroenterology.
Annual Meeting: DGNM online
Sixty-three participants from different disciplines joined the 28th annual meeting of the German Society of Neurogastronenterology and Motility (DGNM) from March 6th to 7th, 2021. Because of ongoing restrictions due to the SARS-COV2 pandemic, the meeting took place online.
Upcoming Events
ESNM is very pleased to announce events with numerous participants, bringing together researchers and clinicians in the extensive field of Neurogastroenterology and Motility. Due to the Covid-19 pandemic, many events are now held virtually. This page lists a selected number of upcoming prime events.
ESNM Meeting
FNM & PNM Meeting
Educational Event
Endorsed Event
Webinar
Membership
ESNM welcomes new applications for membership from clinicians, researchers and others who are interested in the field of Neurogastroenterology, Motility and related disciplines.
About ESNM
Founded in 1982, ESNM has become the leading Scientific Society in the field of Neurogastroenterology and Motility, deeply rooted across Europe and the world. Today 18 affiliated Societies and more than 3,400 members belong to the community. ESNM represents a large network of researchers and clinicians in various fields of medicine (basic, translational and clinical science).
Who we are
ESNM has a specific focus on the neural, endocrine, metabolic, immunological and microbiological regulation of gastrointestinal functions in health and in diseases. Our clinical focus includes functional bowel disorders (irritable bowel syndrome, functional dyspepsia, gastrooesophageal reflux disease, etc.), post-infectious bowel conditions, visceral pain syndromes (e.g. pancreatitis), and non-intestinal disorders with disturbances of intestinal functions.
The mission of ESNM is to expand knowledge and interest in the field, to educate the younger generation of physicians in basic and clinical aspects in the field, to promote scientific and educational events, to encourage basic and clinical research in the field and to establish the standards for good clinical practice and patient care.
Join us on Twitter
Stay up-to-date with the latest news from the European Society of Neurogastroenterology and Motility. Follow us on Twitter!
Latest twitter News
- 2021-09-20 esnm_eu - 📢What a great opportunity! Expand your knowledge with this live educational training, chaired by Jordi Serra: GI Gu… https://t.co/ndliAnGS8U
- 2021-09-20 esnm_eu - RT @ASENEM_: Recomendaciones de formación de @ASENEM_ Dispepsia funcional: de las guías a la práctica clínica. Webinar 23 Septiembre 2021…
- 2021-09-16 esnm_eu - RT @NakovRadislav: Join Bulgaricus - the Bulgarian Neurogastroenterology and Microbiota Congress and learn all the updates on carbohydrate…
- 2021-09-16 esnm_eu - RT @IBS_Maastricht: According to a 🆕 study in @NGMJournal from @BIDMCHealth & @AnthonyLemboMD, it makes sense to focus therapeutic efforts…
